ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nurse Practitioner, Family

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,658Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 459

$515K Total Retail Price of All Prescriptions

Rank: 19 out of 459

303 Patients Receiving at Least One Drug in Part D
67%Patients 65 Years and Older
53% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 303 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

22% of this provider’s 303 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 6,802 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $65 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
OMEPRAZOLE 443 293 1 3
LEVOTHYROXINE SODIUM 399 239 2 5
PRAVASTATIN SODIUM 367 208 3 12
HYDROCHLOROTHIAZIDE 344 266 4 9
HYDROCODONE-ACETAMINOPHEN 337 146 S3 5 2
LISINOPRIL 323 210 6 4
SIMVASTATIN 272 186 7 1
AMLODIPINE BESYLATE 257 209 8 6
METFORMIN HCL 220 116 9 7
METOPROLOL TARTRATE 215 154 10 11
NEXIUM 176 105 11 16
BENAZEPRIL HCL 154 112 12 91
ATENOLOL 154 136 12 14
SERTRALINE HCL 153 112 14 20
FUROSEMIDE 137 109 15 8
ATORVASTATIN CALCIUM 135 77 16 15
POTASSIUM CHLORIDE 131 84 17 24
GABAPENTIN 130 76 18 10
METFORMIN HCL ER 129 58 19 43
ZETIA 126 82 20 62
AMITRIPTYLINE HCL 119 80 R 21 44
LOVASTATIN 118 92 22 37
ZOLPIDEM TARTRATE 108 68 23 19
PROAIR HFA 108 48 23 32
NAMENDA 106 90 25 106
WARFARIN SODIUM 106 91 25 17
DONEPEZIL HCL 104 99 27 64
LOSARTAN POTASSIUM 99 76 28 22
METOPROLOL SUCCINATE 98 58 29 27
FLUOXETINE HCL 96 59 30 47
SINGULAIR 92 62 31 66
ESCITALOPRAM OXALATE 92 45 31 61
PANTOPRAZOLE SODIUM 92 61 31 38
TRAMADOL HCL 92 48 31 13
ALENDRONATE SODIUM 90 78 35 48
PAROXETINE HCL 85 51 36 58
LOSARTAN-HYDROCHLOROTHIAZIDE 84 59 37 49
ALLOPURINOL 80 38 38 52
MELOXICAM 73 43 39 34
DIOVAN 68 45 40 59
CYMBALTA 68 14 40 35
MONTELUKAST SODIUM 67 47 42 127
TAMSULOSIN HCL 67 34 42 33
ADVAIR DISKUS 64 29 44 53
CRESTOR 61 36 45 31
AZITHROMYCIN 59 37 46 25
TRAZODONE HCL 58 31 47 26
FLUTICASONE PROPIONATE 56 41 48 36
CLOPIDOGREL 55 32 49 55
LISINOPRIL-HYDROCHLOROTHIAZIDE 55 33 49 21
CLONIDINE HCL 55 35 49 60
GLIMEPIRIDE 53 47 52 39
CITALOPRAM HBR 52 21 53 18
CARVEDILOL 52 48 53 23
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 22, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.